Healthcare - Biotechnology - NASDAQ - IL
$ 2.23
1.36 %
$ 156 M
Market Cap
-5.57
P/E
CASH FLOW STATEMENT
-18 M
OPERATING CASH FLOW
18.7 M
INVESTING CASH FLOW
5.3 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Alpha Tau Medical Ltd.
| Net Income | -29.2 M |
| Depreciation & Amortization | 1.07 M |
| Capital Expenditures | -6.4 M |
| Stock-Based Compensation | 7.93 M |
| Change in Working Capital | 2.49 M |
| Others | 9.99 M |
| Free Cash Flow | -24.4 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (29.2) | (33.8) | (27.3) | (8.9) | (8.5) |
| Depreciation & Amortization | 1.1 | 1.0 | 0.8 | 86 K | 66 K |
| Deferred Income Tax | (8.9) | 0 | 13.3 | 0.2 | 1.0 |
| Stock Based Compensation | 7.9 | 6.7 | 0.8 | 0.6 | 0.5 |
| Other Operating Activities | 8.6 | 2.5 | 29 K | (0.2) | 12 K |
| Change in Working Capital | 2.5 | (0.3) | 0.6 | 0.9 | 64 K |
| Cash From Operations | (18.0) | (23.9) | (11.8) | (7.3) | (6.9) |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | (6.4) | (0.9) | (2.9) | (3.8) | (1.3) |
| Other Items | 25.1 | (89.0) | 22.2 | (4.0) | (8.9) |
| Cash From Investing Activities | 18.7 | (89.9) | 19.3 | (7.8) | (10.2) |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 5.2 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 49 K | 96.9 | 0.1 | 29.3 | 73 K |
| Cash From Financing Activities | 5.3 | 96.9 | 0.1 | 29.3 | 5.3 |
| CHANGE IN CASH | |||||
| Net Change In Cash | 9.1 | (17.2) | 7.7 | 14.3 | (11.8) |
| FREE CASH FLOW | |||||
| Free Cash Flow | (24.4) | (24.8) | (14.7) | (11.0) | (8.2) |